Ganglioside GM1 deficiency in effector T cells from NOD mice induces resistance to regulatory T-cell suppression

Diabetes

Volumn 60, Issue 9, 2011, Pages 2341-2349

  Wu, Gusheng ^a   Lu, Zi Hua ^a   Gabius, Hans Joachim ^b   Ledeen, Robert W ^a   Bleich, David ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE GM1; TRANSIENT RECEPTOR POTENTIAL CHANNEL 5;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM TRANSPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DIABETES MELLITUS; EFFECTOR CELL; FEMALE; MOUSE; MOUSE STRAIN; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; STRAIN DIFFERENCE; T LYMPHOCYTE ACTIVATION;

ANIMALS; CALCIUM; FEMALE; G(M1) GANGLIOSIDE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED NOD; SPLEEN; T-LYMPHOCYTES; TRPC CATION CHANNELS;

EID: 80052906797     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db10-1309     Document Type: Article

References (50)

1. Bisikirska BC, Herold KC. Regulatory T cells and type 1 diabetes. Curr Diab Rep 2005;5:104-109 (Pubitemid 40823494)
2. + regulatory T lymphocytes in neonatal NOD mice. Ann N Y Acad Sci 2005;1051:72-87
3. D'Alise AM, Auyeung V, Feuerer M, et al. The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors. Proc Natl Acad Sci USA 2008; 105:19857-19862
4. + regulatory T cells. J Immunol 2008;181:7350-7355
5. Ledeen RW, Wu G. Ganglioside function in calcium homeostasis and signaling. Neurochem Res 2002;27:637-647
6. Wu G, Lu Z-H, Obukhov AG, Nowycky MC, Ledeen RW. Induction of calcium influx through TRPC5 channels by cross-linking of GM1 ganglioside associated with α5β1 integrin initiates neurite outgrowth. J Neurosci 2007; 27:7447-7458 (Pubitemid 47066565)
7. Wang J, Lu Z-H, Gabius H-J, Rohowsky-Kochan C, Ledeen RW, Wu G. Crosslinking of GM1 ganglioside by galectin-1 mediates regulatory T cell activity involving TRPC5 channel activation: possible role in suppressing experimental autoimmune encephalomyelitis. J Immunol 2009;182:4036-4045
8. Fishman PH. Role of membrane gangliosides in the binding and action of bacterial toxins. J Membr Biol 1982;69:85-97 (Pubitemid 12036574)
9. Perone MJ, Bertera S, Shufesky WJ, et al. Suppression of autoimmune diabetes by soluble galectin-1. J Immunol 2009;182:2641-2653
10. Vieira KP, de Almeida e Silva Lima Zollner AR,Malaguti C, Vilella CA, de Lima Zollner R. Ganglioside GM1 effects on the expression of nerve growth factor (NGF), Trk-A receptor, proinflammatory cytokines and on autoimmune diabetes onset in non-obese diabetic (NOD) mice. Cytokine 2008;42:92-104
11. Sobel DO, Yankelevich B, Goyal D, Nelson D, Mazumder A. The B-subunit of cholera toxin induces immunoregulatory cells and prevents diabetes in the NOD mouse. Diabetes 1998;47:186-191 (Pubitemid 28079972)
12. Wu GS, Ledeen RW. Quantification of gangliotetraose gangliosides with cholera toxin. Anal Biochem 1988;173:368-375
13. André S, Kaltner H, Furuike T, Nishimura S, Gabius H-J. Persubstituted cyclodextrin-based glycoclusters as inhibitors of protein-carbohydrate recognition using purified plant and mammalian lectins and wild-type and lectin-gene-transfected tumor cells as targets. Bioconjug Chem 2004;15: 87-98 (Pubitemid 38165984)
14. Siebert H-C, André S, Lu SY, et al. Unique conformer selection of human growth-regulatory lectin galectin-1 for ganglioside GM1 versus bacterial toxins. Biochemistry 2003;42:14762-14773 (Pubitemid 37553504)
15. Kaltner H, Seyrek K, Heck A, Sinowatz F, Gabius H-J. Galectin-1 and galectin-3 in fetal development of bovine respiratory and digestive tracts. Comparison of cell type-specific expression profiles and subcellular localization. Cell Tissue Res 2002;307:35-46
16. Lohr M, Lensch M, André S, et al. Murine homodimeric adhesion/growthregulatory galectins-1, -2 and -7: comparative profiling of gene/ promoter sequences by database mining, of expression by RT-PCR/ immunohistochemistry and of contact sites for carbohydrate ligands by computational chemistry. Folia Biol (Praha) 2007;53:109-128 (Pubitemid 47054479)
17. Minke B, Cook B. TRP channel proteins and signal transduction. Physiol Rev 2002;82:429-472 (Pubitemid 34654458)
18. Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 2001;358:221-229 (Pubitemid 32718550)
19. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic selftolerance maintained by activated T cells expressing IL-2 receptor a-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995;155:1151-1164
20. Fontenot JD, Rudensky AY. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol 2005;6:331-337 (Pubitemid 41716769)
21. Kukreja A, Cost G, Marker J, et al. Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest 2002;109:131-140 (Pubitemid 34052549)
22. + regulatory T-cells in type 1 diabetes. Diabetes 2007;56:604-612
23. high regulatory T cells in human autoimmune diabetes. J Autoimmun 2005;24:55-62
24. +) T-cells from patients with type 1 diabetes. Diabetes 2005;54:92-99
25. + regulatory T cells. Immunology 2007;121:15-28
26. + regulatory T-cells contributes to the onset of autoimmune diabetes. Diabetes 2008;57:113-123
27. Oling V, Marttila J, Knip M, Simell O, Ilonen J. Circulating CD4+CD25 high regulatory T cells and natural killer T cells in children with newly diagnosed type 1 diabetes or with diabetes-associated autoantibodies. Ann N Y Acad Sci 2007;1107:363-372 (Pubitemid 47528813)
28. You S, Belghith M, Cobbold S, et al. Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells. Diabetes 2005;54:1415-1422 (Pubitemid 40586672)
29. Gregori S, Giarratana N, Smiroldo S, Adorini L. Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development. J Immunol 2003;171:4040-4047 (Pubitemid 37238678)
30. Wu G, Ledeen RW. Gangliosides as modulators of neuronal calcium. Prog Brain Res 1994;101:101-112 (Pubitemid 24084740)
31. Wang P, Zhang J, Bian H, et al. Induction of lysosomal and plasma membrane-bound sialidases in human T-cells via T-cell receptor. Biochem J 2004;380:425-433 (Pubitemid 38788114)
32. Brumeanu T-D, Preda-Pais A, Stoica C, Bona C, Casares S. Differential partitioning and trafficking of GM gangliosides and cholesterol-rich lipid rafts in thymic and splenic CD4 T cells. Mol Immunol 2007;44:530-540 (Pubitemid 44287046)
33. Tuosto L, Parolini I, Schröder S, Sargiacomo M, Lanzavecchia A, Viola A. Organization of plasma membrane functional rafts upon T cell activation. Eur J Immunol 2001;31:345-349 (Pubitemid 32166587)
34. Gabius H-J (Ed.). The Sugar Code. Fundamentals of Glycosciences. Weinheim, Germany, Wiley-VCH, 2009
35. Ola TO, Williams NA. Protection of non-obese diabetic mice from autoimmune diabetes by Escherichia coli heat-labile enterotoxin B subunit. Immunology 2006;117:262-270
36. Salmond RJ, Luross JA, Williams NA. Immune modulation by the choleralike enterotoxins. Expert Rev Mol Med 2002;4:1-16
37. + T cells. Blood 2007;109:2058-2065
38. Cooper DN, Barondes SH. Evidence for export of a muscle lectin from cytosol to extracellular matrix and for a novel secretory mechanism. J Cell Biol 1990;110:1681-1691 (Pubitemid 20169506)
39. H-17 effector cells selectively regulates susceptibility to cell death. Nat Immunol 2007;8:825-834
40. Offner H, Celnik B, Bringman TS, Casentini-Borocz D, Nedwin GE, Vandenbark AA. Recombinant human β-galactoside binding lectin suppresses clinical and histological signs of experimental autoimmune encephalomyelitis. J Neuroimmunol 1990;28:177-184 (Pubitemid 20187691)
41. Rabinovich GA, Daly G, Dreja H, et al. Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis. J Exp Med 1999;190:385-398
42. Santucci L, Fiorucci S, Rubinstein N, et al. Galectin-1 suppresses experimental colitis in mice. Gastroenterology 2003;124:1381-1394 (Pubitemid 36531812)
43. Santucci L, Fiorucci S, Cammilleri F, Servillo G, Federici B, Morelli A. Galectin-1 exerts immunomodulatory and protective effects on concanavalin A-induced hepatitis in mice. Hepatology 2000;31:399-406 (Pubitemid 30078605)
44. Rappl G, Abken H, Muche JM, et al. CD4+CD7- leukemic T cells from patients with Sézary syndrome are protected from galectin-1-triggered T cell death. Leukemia 2002;16:840-845 (Pubitemid 34537556)
45. André S, Sanchez-Ruderisch H, Nakagawa H, et al. Tumor suppressor p16INK4a - modulator of glycomic profile and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells. FEBS J 2007;274:3233-3256 (Pubitemid 47028461)
46. Kopitz J. Glycolipids. In The Sugar Code. Fundamentals of Glycosciences. Gabius H-J, Ed. Weinheim, Germany, Wiley-VCH, 2009, p. 177-198
47. Kopitz J, von Reitzenstein C, André S, et al. Negative regulation of neuroblastoma cell growth by carbohydrate-dependent surface binding of galectin-1 and functional divergence from galectin-3. J Biol Chem 2001; 276:35917-35923
48. 1, a product of the growth-controlling activity of a cell surface ganglioside sialidase, on human neuroblastoma cells in culture. J Biol Chem 1998;273:11205-11211
49. Clapham DE, Runnels LW, Strübing C. The TRP ion channel family. Nat Rev Neurosci 2001;2:387-396 (Pubitemid 33674795)
50. + T cells in autoimmunity. Curr Opin Immunol 2005;17:624-631